Are you Struggling With Losing Weight?
The purpose of this study is to find out whether an experimental medication helps people living with obesity, to lose weight.
This clinical trial is designed to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine to those of participants who take placebo (a lookalike substance that contains no active study medicine). The aim is to measure the body’s response to the study medicine, including any changes in participants’ body weight and how well they tolerate the study medicine.
Would you like to take part?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your health to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others struggling with obesity and weight loss, and whether it will be made widely available to all Canadians trying to manage obesity. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Are male or non-pregnant, non-breastfeeding female
- Are 18 to 74 years of age at time of screening
- Have a Body Mass Index ≥30.0 kg/m2 at Visit 1, with stable body weight, defined as <5 kg change in the 12 weeks before Visit 1
- Are eligible and willing to receive required background medicine
- Are willing and able to comply with all study procedures
You may not qualify to participate if you:
- Have any medical or psychiatric condition or laboratory abnormality, or recent serious illness or hospitalization, that may increase the risk of study participation or, in the investigator’s judgment, make the participant inappropriate for the study including diagnosis of type 2 diabetes mellitus, type 1 or secondary forms of diabetes.
- Use any prohibited prior or concomitant medication(s)
- Present any specified abnormalities on diagnostic assessments including clinical laboratory tests at Visit 1
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.
